Abstract
Purpose
Many studies have investigated the association between intestinal barrier impairment and the onset of atopic dermatitis (AD). The gut microbiota is essential to maintain physiological homeostasis and immune regulation of host. Therefore, the objectives were to determine the effects of probiotics on the clinical symptoms, immune responses, and gut microbiota in AD patients.
Methods
109 patients were randomly divided into 4 groups, including placebo group, oligosaccharides group, Bifidobacterium bifidum CCFM16 group, and Lactobacillus plantarum CCFM8610 group. At the end of the experiment, serological indicators, SCORAD, and DLQI indices were assessed. V3–V4 region of the 16S ribosomal RNA gene was sequenced to evaluate changes in the gut microbiota. Linear discriminant analysis (LDA) effect size was used to uncover microbial biomarkers and PICRUSt (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) was used to predict gene family abundances based on 16S information.
Results
The results demonstrated that CCFM8610 significantly decreased the SCORAD index, and increased the serum IL-10 levels. Supplement with CCFM8610 and CCFM16 significantly influenced the alpha diversity, increased the proportion of Bacteroidetes, and reduced the F/B ratio. CCFM8610 treatment downregulated the functional genes of gut microbiota involving Staphylococcus aureus infection and upregulated the steroid hormone biosynthesis.
Conclusion
The results indicated a positive correlation between decreased SCORAD index and CCFM8610 treatment, and that CCFM8610 regulated the immune responses in AD patients. CCFM8610 treatment influences the gut microbiota composition and functional changes. In conclusion, L. plantarum CCFM8610 exerts the strain-specific amelioration effects on patients with AD.
Trial registration: ChiCTR1800015330 (Clinicaltrials.gov Identifier).
Similar content being viewed by others
Change history
15 October 2021
A Correction to this paper has been published: https://doi.org/10.1007/s00394-021-02705-x
References
Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112(6 Suppl):S118–S127. https://doi.org/10.1016/j.jaci.2003.09.033
Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242(1):233–246. https://doi.org/10.1111/j.1600-065X.2011.01027.x
Weidinger S, Novak N (2016) Atopic dermatitis. Lancet 387(10023):1109–1122. https://doi.org/10.1016/s0140-6736(15)00149-x
Buzney CD, Gottlieb AB, Rosmarin D (2016) Asthma and atopic dermatitis: a review of targeted inhibition of interleukin-4 and interleukin-13 as therapy for atopic disease. J Drugs Dermatol JDD 15(2):165–171
Kim GD, Seek PY, Ahn HJ, Cho JJ, Park CS (2015) Aspartame attenuates 2, 4-dinitrofluorobenzene-induced atopic dermatitis-like clinical symptoms in NC/Nga mice. J Investig Dermatol 135(11):2705–2713. https://doi.org/10.1038/jid.2015.234
Celakovska J, Bukac J (2016) The severity of atopic dermatitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopic dermatitis. Allergy Rhinol (Providence, RI) 7(1):8–13. https://doi.org/10.2500/ar.2016.7.0144
Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138(2):336–349. https://doi.org/10.1016/j.jaci.2016.06.010
Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30(11):1604–1610. https://doi.org/10.1046/j.1365-2222.2000.00943.x
Yamamoto K, Yokoyama K, Matsukawa T, Kato S, Kato S, Yamada K, Hirota T (2016) Efficacy of prolonged ingestion of Lactobacillus acidophilus L-92 in adult patients with atopic dermatitis. J Dairy Sci 99(7):5039–5046. https://doi.org/10.3168/jds.2015-10605
Navarrolópez V, Ramírezboscá A, Ramónvidal D, Ruzafacostas B, Genovésmartínez S, Chenollcuadros E, Carrióngutiérrez M, Horga JDLP, Prietomerino D, Codoñercortés FM (2018) Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial. Jama Dermatol 154(1):37–43. https://doi.org/10.1001/jamadermatol.2017.3647
Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS (2012) Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy 42(1):112–122. https://doi.org/10.1111/j.1365-2222.2011.03885.x
Brouwer ML, Wolt-Plompen SA, Dubois AE, van der Heide S, Jansen DF, Hoijer MA, Kauffman HF, Duiverman EJ (2006) No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy J Br Soc Allergy Clin Immunol 36(7):899–906. https://doi.org/10.1111/j.1365-2222.2006.02513.x
Taylor AL, Dunstan JA, Prescott SL (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119(1):184–191. https://doi.org/10.1016/j.jaci.2006.08.036
Zhai Q, Wang G, Zhao J, Liu X, Narbad A, Chen YQ, Zhang H, Tian F, Chen W (2014) Protective effects of Lactobacillus plantarum CCFM8610 against chronic cadmium toxicity in mice indicate routes of protection besides intestinal sequestration. Appl Environ Microbiol 80(13):4063–4071. https://doi.org/10.1128/aem.00762-14
Wang L, Hu L, Xu Q, Jiang T, Fang S, Wang G, Zhao J, Zhang H, Chen W (2017) Bifidobacteria exert species-specific effects on constipation in BALB/c mice. Food Funct 8(10):3587–3600. https://doi.org/10.1039/c6fo01641c
Wang L, Hu L, Yan S, Jiang T, Fang S, Wang G, Zhao J, Zhang H, Chen W (2017) Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation. Food Funct 8(5):1966–1978. https://doi.org/10.1039/c7fo00031f
Hu L, Lu W, Wang L, Pan M, Zhang H, Zhao J, Chen W (2017) Assessment of Bifidobacterium species using groEL gene on the basis of Illumina MiSeq high-throughput sequencing. Genes 8(11):336. https://doi.org/10.3390/genes8110336
Langille MGI, Jesse Z, Caporaso JG, Daniel MD, Dan K, Reyes JA, Clemente JC, Burkepile DE, Thurber RL, Vega Rob K (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31(9):814–821. https://doi.org/10.1038/nbt.2676
Parks DH, Tyson GW, Hugenholtz P, Beiko RG (2014) STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics (Oxford, England) 30(21):3123–3124. https://doi.org/10.1093/bioinformatics/btu494
Avershina E, Cabrera-Rubio R, Lundgård K, Perez-Martinez G, Collado MC, Storrø O, Øien T, Dotterud CK, Johnsen R, Rudi K (2017) Effect of probiotics in prevention of atopic dermatitis is dependent on the intrinsic microbiota at early infancy. J Allergy Clin Immunol 139(4):1399–1402. https://doi.org/10.1016/j.jaci.2016.09.056
Chapman CM, Gibson GR, Rowland I (2011) Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 50(1):1–17. https://doi.org/10.1007/s00394-010-0166-z
Wang L, Hu L, Xu Q, Yin B, Fang D, Wang G, Zhao J, Zhang H, Chen W (2017) Bifidobacterium adolescentis exerts strain-specific effects on constipation induced by Loperamide in BALB/c mice. Int J Mol Sci 18(2):318. https://doi.org/10.3390/ijms18020318
Onur B, Thomas W, Akdis CA (2012) The suppressive role of IL-10 in contact and atopic dermatitis. J Allergy Clin Immunol 129(1):160–161. https://doi.org/10.1016/j.jaci.2011.10.046
Girard-Madoux MJH, Kel JM, Reizis B, Clausen BE (2012) IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J Allergy Clin Immunol 129(1):143–150. https://doi.org/10.1016/j.jaci.2011.08.032
Oh SH, Park CO, Wu WH, Kim JY, Jin S, Byamba D, Bae BG, Noh S, Lim BJ, Noh JY (2012) Corticotropin-releasing hormone downregulates IL-10 production by adaptive forkhead box protein 3-negative regulatory T cells in patients with atopic dermatitis. J Allergy Clin Immunol 129(1):151–159. https://doi.org/10.1016/j.jaci.2011.09.008
Lee M-J, Kang M-J, Lee S-Y, Lee E, Kim K, Won S, Suh DI, Kim KW, Sheen YH, Ahn K, Kim B-S, Hong S-J (2018) Perturbations of gut microbiome genes in infants with atopic dermatitis according to feeding type. J Allergy Clin Immunol 141(4):1310–1319. https://doi.org/10.1016/j.jaci.2017.11.045
Björkstén Naaber, Sepp Mikelsaar (1999) The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29(3):342–346. https://doi.org/10.1046/j.1365-2222.1999.00560.x
Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108(4):516–520. https://doi.org/10.1067/mai.2001.118130
Michail SK, Stolfi A, Johnson T, Onady GM (2008) Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 101(5):508–516. https://doi.org/10.1016/s1081-1206(10)60290-6
Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park YH (2016) Probiotics and atopic dermatitis: an overview. Front Microbiol 7:507. https://doi.org/10.3389/fmicb.2016.00507
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, NY) 341(6145):569–573. https://doi.org/10.1126/science.1241165
Kwon M-S, Lim SK, Jang J-Y, Lee J, Park HK, Kim N, Yun M, Shin M-Y, Jo HE, Oh YJ, Roh SW, Choi H-J (2018) Lactobacillus sakei WIKIM30 ameliorates atopic dermatitis-like skin lesions by inducing regulatory T cells and altering gut microbiota structure in mice. Front Immunol 9:1905. https://doi.org/10.3389/fimmu.2018.01905
Wan Y, Wang F, Yuan J, Li J, Jiang D, Zhang J, Li H, Wang R, Tang J, Huang T, Zheng J, Sinclair AJ, Mann J, Li D (2019) Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. https://doi.org/10.1136/gutjnl-2018-317609
Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M (2003) Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol 111(3):587–591. https://doi.org/10.1067/mai.2003.105
Hevia A, Milani C, López P, Donado CD, Cuervo A, González S, Suárez A, Turroni F, Gueimonde M, Ventura M (2016) Allergic patients with long-term asthma display low levels of bifidobacterium adolescentis. PLoS One 11(2):e0147809. https://doi.org/10.1371/journal.pone.0147809
Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, BäCkhed F, Lusis AJ (2018) Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol 3(12):1461–1471. https://doi.org/10.1038/s41564-018-0272-x
Wu F, Guo X, Zhang J, Zhang M, Ou Z, Peng Y (2017) Phascolarctobacterium faecium abundant colonization in human gastrointestinal tract. Exp Ther Med 14(4):3122–3126. https://doi.org/10.3892/etm.2017.4878
Li Z, Quan G, Jiang X, Yang Y, Ding X, Zhang D, Wang X, Hardwidge PR, Ren W, Zhu G (2018) Effects of metabolites derived from gut microbiota and hosts on pathogens. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2018.00314
Acknowledgements
We would like to thank the Tinghu People’s hospital, Yancheng, and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.
Funding
This research was funded by the National Natural Science Foundation of China (Nos. 31871774, 31771953, and 31820103010), the National First-class Discipline Program of Food Science and Technology (JUFSTR20180102), the Fundamental Research Funds for the Central Universities (JUSRP51903B),and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
The study was approved by the medical ethics committee of the Tinghu People’s Hospital, Yancheng (Ethical No. ET2017016), Jiangsu province, China.
Rights and permissions
About this article
Cite this article
Fang, Z., Lu, W., Zhao, J. et al. Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study. Eur J Nutr 59, 2119–2130 (2020). https://doi.org/10.1007/s00394-019-02061-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-019-02061-x